Johnson Kevin Bruce has filed 7 insider transactions across 1 company since January 2025.
Most recent transaction: a disposition of 11046 shares of Tourmaline Bio, Inc. ($TRML) on October 28, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | D | Common Stock | 11046 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.04% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | D | Employee Stock Option (Right to Buy) | 46774 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.18% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | D | Employee Stock Option (Right to Buy) | 58000 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.23% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | U | Common Stock | 40538 | $0.00 | 11,046.0000 | 25,755,000 | 78.59% | 0.16% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | D | Employee Stock Option (Right to Buy) | 96146 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.37% |
| Oct. 15, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | G | Common Stock | 6250 | $0.00 | 51,584.0000 | 25,755,000 | 10.81% | 0.02% |
| Jan. 27, 2025 | Tourmaline Bio, Inc. | $TRML | Johnson Kevin Bruce | Chief Regulatory Officer | A | Employee Stock Option (Right to Buy) | 58000 | $0.00 | 58,000.0000 | 25,348,000 | 9999.99% | 0.23% |